middle.news
Recce Pharmaceuticals Secures 10-Year Licensing Deal for R327 Gel in MENA
9:48am on Wednesday 27th of May, 2026 AEST
•
Healthcare
Read Story
Recce Pharmaceuticals Secures 10-Year Licensing Deal for R327 Gel in MENA
9:48am on Wednesday 27th of May, 2026 AEST
Key Points
10-year exclusive licensing term sheet signed
Upfront and milestone payments up to USD 3.5 million
Royalties include 30% net sales plus 6% on sales above USD 50 million
Regulatory submission to leverage ongoing Phase 3 trial data
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE